139 related articles for article (PubMed ID: 23073581)
1. Perturbation of the transforming growth factor β system in Turner syndrome.
Zhou J; Arepalli S; Cheng CM; Bakalov VK; Bondy CA
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):720-4. PubMed ID: 23073581
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
3. Altered autophagy induction by sera from pregnant women with pre-eclampsia: a case-control study.
Kanninen TT; Jayaram A; Jaffe Lifshitz S; Witkin SS
BJOG; 2014 Jul; 121(8):958-64. PubMed ID: 24690242
[TBL] [Abstract][Full Text] [Related]
4. Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study.
Dietmann A; Lackner P; Fischer M; Broessner G; Pfausler B; Helbok R; Schmutzhard E; Beer R
Cerebrovasc Dis; 2012; 33(1):16-22. PubMed ID: 22133666
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma.
Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
Mol Med Rep; 2015 Jun; 11(6):4508-12. PubMed ID: 25625662
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1 and its receptor soluble endoglin are altered in polycystic ovary syndrome during controlled ovarian stimulation.
Tal R; Seifer DB; Shohat-Tal A; Grazi RV; Malter HE
Fertil Steril; 2013 Aug; 100(2):538-43. PubMed ID: 23684116
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.
Juraskova B; Andrys C; Holmerova I; Solichova D; Hrnciarikova D; Vankova H; Vasatko T; Krejsek J
J Nutr Health Aging; 2010 Nov; 14(9):758-61. PubMed ID: 21085906
[TBL] [Abstract][Full Text] [Related]
8. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
9. Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
Bozas G; Terpos E; Gika D; Karadimou A; Dimopoulos MA; Bamias A
Int J Gynecol Cancer; 2010 Feb; 20(2):248-54. PubMed ID: 20134268
[TBL] [Abstract][Full Text] [Related]
10. Soluble endoglin and transforming growth factor-beta1 in women who subsequently developed preeclampsia.
Lim JH; Kim SY; Park SY; Lee MH; Yang JH; Kim MY; Chung JH; Lee SW; Ryu HM
Prenat Diagn; 2009 May; 29(5):471-6. PubMed ID: 19253312
[TBL] [Abstract][Full Text] [Related]
11. The TGFβ system and TIMP1 and 3 genotypes in Turner syndrome-Relation with aortic congenital malformations.
Ridder LO; Stochholm K; Mortensen KH; Andersen NH; Gravholt CH
Clin Endocrinol (Oxf); 2023 Dec; 99(6):545-551. PubMed ID: 36890688
[TBL] [Abstract][Full Text] [Related]
12. Increased intrahepatic and circulating levels of endoglin, a TGF-beta1 co-receptor, in patients with chronic hepatitis C virus infection: relationship to histological and serum markers of hepatic fibrosis.
Clemente M; Núñez O; Lorente R; Rincón D; Matilla A; Salcedo M; Catalina MV; Ripoll C; Iacono OL; Bañares R; Clemente G; García-Monzón C
J Viral Hepat; 2006 Sep; 13(9):625-32. PubMed ID: 16907850
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.
Bot PT; Hoefer IE; Sluijter JP; van Vliet P; Smits AM; Lebrin F; Moll F; de Vries JP; Doevendans P; Piek JJ; Pasterkamp G; Goumans MJ
Stroke; 2009 Feb; 40(2):439-47. PubMed ID: 19074480
[TBL] [Abstract][Full Text] [Related]
14. Immunodetection and characterisation of soluble CD105-TGFbeta complexes.
Li CG; Wilson PB; Bernabeu C; Raab U; Wang JM; Kumar S
J Immunol Methods; 1998 Sep; 218(1-2):85-93. PubMed ID: 9819125
[TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of anti-angiogenic factors soluble fms-like tyrosine kinase and soluble endoglin in sickle cell disease.
Landburg PP; Elsenga H; Schnog JB; Duits AJ;
Acta Haematol; 2008; 120(3):130-3. PubMed ID: 19039203
[TBL] [Abstract][Full Text] [Related]
16. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis.
Jamdar S; Al-Mowallad AF; Kumar S; Siriwardena AK
Pancreas; 2006 Mar; 32(2):152-8. PubMed ID: 16552334
[TBL] [Abstract][Full Text] [Related]
17. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration.
Ma X; Labinaz M; Goldstein J; Miller H; Keon WJ; Letarte M; O'Brien E
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2546-52. PubMed ID: 11116051
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 and -β2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitro.
Ma GF; Miao Q; Zeng XQ; Luo TC; Ma LL; Liu YM; Lian JJ; Gao H; Chen SY
PLoS One; 2013; 8(1):e54249. PubMed ID: 23342108
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β and inflammation in vascular (type IV) Ehlers-Danlos syndrome.
Morissette R; Schoenhoff F; Xu Z; Shilane DA; Griswold BF; Chen W; Yang J; Zhu J; Fert-Bober J; Sloper L; Lehman J; Commins N; Van Eyk JE; McDonnell NB
Circ Cardiovasc Genet; 2014 Feb; 7(1):80-8. PubMed ID: 24399159
[TBL] [Abstract][Full Text] [Related]
20. A clue for telangiectasis in systemic sclerosis: elevated serum soluble endoglin levels in patients with the limited cutaneous form of the disease.
Fujimoto M; Hasegawa M; Hamaguchi Y; Komura K; Matsushita T; Yanaba K; Kodera M; Takehara K; Sato S
Dermatology; 2006; 213(2):88-92. PubMed ID: 16902284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
